| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review Article |
1 From the Phytonutrients Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture, Beltsville, MD (SJB), and the Department of Medicine, George Washington University Medical Center, Washington DC (MTV).
Evidence is emerging that dietary phytoestrogens play a beneficial role in obesity and diabetes. Nutritional intervention studies performed in animals and humans suggest that the ingestion of soy protein associated with isoflavones and flaxseed rich in lignans improves glucose control and insulin resistance. In animal models of obesity and diabetes, soy protein has been shown to reduce serum insulin and insulin resistance. In studies of human subjects with or without diabetes, soy protein also appears to moderate hyperglycemia and reduce body weight, hyperlipidemia, and hyperinsulinemia, supporting its beneficial effects on obesity and diabetes. However, most of these clinical trials were relatively short and involved a small number of patients. Furthermore, it is not clear whether the beneficial effects of soy protein and flaxseed are due to isoflavones (daidzein and genistein), lignans (matairesinol and secoisolariciresinol), or some other component. Isoflavones and lignans appear to act through various mechanisms that modulate pancreatic insulin secretion or through antioxidative actions. They may also act via estrogen receptor–mediated mechanisms. Some of these actions have been shown in vitro, but the relevance of these studies to in vivo disease is not known. The diversity of cellular actions of isoflavones and lignans supports their possible beneficial effects on various chronic diseases. Further investigations are needed to evaluate the long-term effects of phytoestrogens on obesity and diabetes mellitus and their associated possible complications.
Key Words: Obesity • diabetes mellitus • diet • soybean • soy protein • phytoestrogens • isoflavones • flaxseed • lignans • glucose • insulin resistance • antioxidative actions • hyperlipidemia • pancreatic ß cells
This article has been cited by other articles:
|
|
 |
|
  A. Pan, O. H. Franco, J. Ye, W. Demark-Wahnefried, X. Ye, Z. Yu, H. Li, and X. Lin Soy Protein Intake Has Sex-Specific Effects on the Risk of Metabolic Syndrome in Middle-Aged and Elderly Chinese J. Nutr., December 1, 2008; 138(12): 2413 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Trujillo, C. Cruz, A. Tovar, V. Vaidya, E. Zambrano, J. V. Bonventre, G. Gamba, N. Torres, and N. A. Bobadilla Renoprotective mechanisms of soy protein intake in the obese Zucker rat Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1574 - F1582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bhatia, F. Greer, and and the Committee on Nutrition Use of Soy Protein-Based Formulas in Infant Feeding Pediatrics, May 1, 2008; 121(5): 1062 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Villegas, Y.-T. Gao, G. Yang, H.-L. Li, T. A Elasy, W. Zheng, and X. O. Shu Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study Am. J. Clinical Nutrition, January 1, 2008; 87(1): 162 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. Lin, H.-C. Huang, and J.-K. Lin Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells J. Lipid Res., November 1, 2007; 48(11): 2334 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Atteritano, H. Marini, L. Minutoli, F. Polito, A. Bitto, D. Altavilla, S. Mazzaferro, R. D'Anna, M. L. Cannata, A. Gaudio, et al. Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3068 - 3075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wu, M. C. Yu, C.-C. Tseng, F. Z. Stanczyk, and M. C. Pike Diabetes and risk of breast cancer in Asian-American women Carcinogenesis, July 1, 2007; 28(7): 1561 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Huang, F. Shi, T. Lei, Y. Song, C. L. Hughes, and G. Liu Effect of the Isoflavone Genistein Against Galactose-Induced Cataracts in Rats Experimental Biology and Medicine, January 1, 2007; 232(1): 118 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M.J. Conklin, J. F. Bechberger, D. MacFabe, N. Guthrie, E. M. Kurowska, and C. C. Naus Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells Carcinogenesis, January 1, 2007; 28(1): 93 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mizoue, T. Yamaji, S. Tabata, K. Yamaguchi, S. Ogawa, M. Mineshita, and S. Kono Dietary Patterns and Glucose Tolerance Abnormalities in Japanese Men J. Nutr., May 1, 2006; 136(5): 1352 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Cruz, L. Luksha, H. Logman, L. Poston, S. Agewall, and K. Kublickiene Acute responses to phytoestrogens in small arteries from men with coronary heart disease Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1969 - H1975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Shen, M. H. Liu, T. Y. Ng, Y. H. Chan, and E. L. Yong Differential Effects of Isoflavones, from Astragalus Membranaceus and Pueraria Thomsonii, on the Activation of PPAR{alpha}, PPAR{gamma}, and Adipocyte Differentiation In Vitro J. Nutr., April 1, 2006; 136(4): 899 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Souzeau, S. Belanger, S. Picard, and C. F. Deschepper Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H715 - H721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Woclawek-Potocka, T. J. Acosta, A. Korzekwa, M. M. Bah, M. Shibaya, K. Okuda, and D. J. Skarzynski Phytoestrogens Modulate Prostaglandin Production in Bovine Endometrium: Cell Type Specificity and Intracellular Mechanisms Experimental Biology and Medicine, May 1, 2005; 230(5): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Baker and K. L. Hamilton Genistein stimulates electrogenic Cl- secretion in mouse jejunum Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1636 - C1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mullen, R. M. Brown, T. F. Osborne, and N. F. Shay Soy Isoflavones Affect Sterol Regulatory Element Binding Proteins (SREBPs) and SREBP-Regulated Genes in HepG2 Cells J. Nutr., November 1, 2004; 134(11): 2942 - 2947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Selvaraj, M. A. Zakroczymski, A. Naaz, M. Mukai, Y. H. Ju, D. R. Doerge, J. A. Katzenellenbogen, W. G. Helferich, and P. S. Cooke Estrogenicity of the Isoflavone Metabolite Equol on Reproductive and Non-Reproductive Organs in Mice Biol Reprod, September 1, 2004; 71(3): 966 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.M.N. Ratnayake, G.S. Gilani, S. J. Bhathena, A. A. Ali, C. Haudenschild, P. Latham, T. Ranich, A. I. Mohamed, C. T. Hansen, and M. T. Velasquez Letters to the Editor J. Am. Coll. Nutr., August 1, 2003; 22(4): 326 - 329. [Full Text] [PDF]
|
|
|
|
|
|
O. Mezei, W. J. Banz, R. W. Steger, M. R. Peluso, T. A. Winters, and N. Shay Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells J. Nutr., May 1, 2003; 133(5): 1238 - 1243. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
